GIT1 is a novel prognostic biomarker and facilitates tumor progression via activating ERK/MMP9 signaling in hepatocellular carcinoma

AIM: Multiple studies have revealed that G-protein-coupled receptor kinase-interacting protein 1 (GIT1) is overexpressed in many cancers and facilitates tumor progression. However, the role of GIT1 in hepatocellular carcinoma (HCC) remains unclear. METHODS: GIT1 expression was detected in cell lines...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Junyi, Yang, Pinghua, Yang, Jue, Wen, Zhijian, Zhang, Baohua, Zheng, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689273/
https://www.ncbi.nlm.nih.gov/pubmed/26719701
http://dx.doi.org/10.2147/OTT.S96715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689273/
https://www.ncbi.nlm.nih.gov/pubmed/26719701
http://dx.doi.org/10.2147/OTT.S96715

Ejemplares similares